BACKGROUND: There have been conflicting reports in the literature on association of gene copy number with disease, including CCL3L1 and HIV susceptibility, and β-defensins and Crohn's disease. Quantification of precise gene copy numbers is important in order to define any association of gene copy number with disease. At present, real-time quantitative PCR (QPCR) is the most commonly used method to determine gene copy number, however the Paralogue Ratio Test (PRT) is being used in more and more laboratories. FINDINGS: In this study we compare a Pyrosequencing-based Paralogue Ratio Test (PPRT) for determining beta-defensin gene copy number with two currently used methods for gene copy number determination, QPCR and triplex PRT by typing five different cohorts (UK, Danish, Portuguese, Ghanaian and Czech) of DNA from a total of 576 healthy individuals. We found a systematic measurement bias between DNA cohorts revealed by QPCR, but not by the PRT-based methods. Using PRT, copy number ranged from 2 to 9 copies, with a modal copy number of 4 in all populations. CONCLUSIONS: QPCR is very sensitive to quality of the template DNA, generating systematic biases that could produce false-positive or negative disease associations. Both triplex PRT and PPRT do not show this systematic bias, and type copy number within the correct range, although triplex PRT appears to be a more precise and accurate method to type beta-defensin copy number.

Department for Microbiological Surveillance and Research Statens Serum Institut Copenhagen Denmark

Zobrazit více v PubMed

Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454. PubMed PMC

Carter NP. Methods and strategies for analyzing copy number variation using DNA microarrays. Nat Genet. 2007;39:S16–S21. PubMed PMC

Pinto D, Marshall C, Feuk L, Scherer SW. Copy-number variation in control population cohorts. Hum Mol Genet 16 Spec No. 2007;2:R168–R173. PubMed

Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, et al. Origins and functional impact of copy number variation in the human genome. Nature. 2010;464:704–712. PubMed PMC

Kidd JM, Cooper GM, Donahue WF, Hayden HS, Sampas N, et al. Mapping and sequencing of structural variation from eight human genomes. Nature. 2008;453:56–64. PubMed PMC

Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, et al. Paired-end mapping reveals extensive structural variation in the human genome. Science. 2007;318:420–426. PubMed PMC

Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525–528. PubMed

Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949–951. PubMed

Altshuler D, Daly MJ, Lander ES. Genetic mapping in human disease. Science. 2008;322:881–888. PubMed PMC

Hollox EJ, Huffmeier U, Zeeuwen PL, Palla R, Lascorz J, et al. Psoriasis is associated with increased beta-defensin genomic copy number. Nat Genet. 2008;40:23–25. PubMed PMC

de Cid R, Riveira-Munoz E, Zeeuwen PL, Robarge J, Liao W, et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet. 2009;41:211–215. PubMed PMC

Huffmeier U, Bergboer JGM, Becker T, Armour JA, Traupe H, et al. Replication of LCE3C-LCE3B CNV as a Risk Factor for Psoriasis and Analysis of Interaction with Other Genetic Risk Factors. J Invest Dermatol. 2010;130:979–984. PubMed

Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet. 2008;9:341–355. PubMed PMC

Huse K, Taudien S, Groth M, Rosenstiel P, Szafranski K, et al. Genetic variants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer. Tumour Biol. 2008;29:83–92. PubMed

Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232–236. PubMed PMC

Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539–543. PubMed

Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, et al. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet. 2008;40:880–885. PubMed

Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, et al. Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature. 2006;439:851–855. PubMed

Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, et al. FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 2007;39:721–723. PubMed PMC

Yang Y, Chung EK, Wu YL, Savelli SL, Nagaraja HN, et al. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet. 2007;80:1037–1054. PubMed PMC

Heinzen EL, Need AC, Hayden KM, Chiba-Falek O, Roses AD, et al. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis. 2010;19:69–77. PubMed PMC

Weterman MA, van Ruissen F, de Wissel M, Bordewijk L, Samijn JP, et al. Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease. Eur J Hum Genet. 2010;18:421–428. PubMed PMC

Zhang F, Seeman P, Liu P, Gonzaga-Jauregui C, Towne CF, et al. Mechanisms for Nonrecurrent Genomic Rearrangements Associated with CMT1A or HNPP: Rare CNVs as a Cause for Missing Heritability. The American Journal of Human Genetics. 2010;86:892–903. PubMed PMC

Thomas B, Beal MF. Parkinson's disease. Human Molecular Genetics. 2007;16:R183–R194. PubMed

Schaschl H, Aitman TJ, Vyse TJ. Copy number variation in the human genome and its implication in autoimmunity. Clin Exp Immunol. 2009;156:12–16. PubMed PMC

Aldred PM, Hollox EJ, Armour JA. Copy number polymorphism and expression level variation of the human alpha-defensin genes DEFA1 and DEFA3. Hum Mol Genet. 2005;14:2045–2052. PubMed

Linzmeier R, Ho CH, Hoang BV, Ganz T. A 450-kb contig of defensin genes on human chromosome 8p23. Gene. 1999;233:205–211. PubMed

Hollox EJ, Armour JA, Barber JC. Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am J Hum Genet. 2003;73:591–600. PubMed PMC

Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol. 2003;3:710–720. PubMed

Chertov O, Michiel DF, Xu L, Wang JM, Tani K, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271:2935–2940. PubMed

Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, et al. Beta-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6. Science. 1999;286:525–528. PubMed

Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30:131–141. PubMed PMC

Niyonsaba F, Ushio H, Nagaoka I, Okamura K, Ogawa H. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol. 2005;175:1776–1784. PubMed

Boniotto M, Jordan WJ, Eskdale J, Tossi A, Antcheva N, et al. Human beta-defensin 2 induces a vigorous cytokine response in peripheral blood mononuclear cells. Antimicrob Agents Chemother 206. 2006;50:1433–1441. PubMed PMC

Jin G, Kawsar HI, Hirsch SA, Zeng C, Jia X, et al. An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis. PLoS One. 2010;5:e10993-. PubMed PMC

Candille SI, Kaelin CB, Cattanach BM, Yu B, Thompson DA, et al. A β-defensin mutation causes black coat color in domestic dogs. Science. 2007;318:1418–1423. PubMed PMC

Semple F, Webb S, Li HN, Patel HB, Perretti M, et al. Human beta-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol. 2010;40:1073–1078. PubMed PMC

Hollox EJ, Davies J, Griesenbach U, Burgess J, Alton EW, et al. Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis. J Negat Results Biomed. 2005;4:9-. PubMed PMC

Hollox EJ. Copy number variation of beta-defensins and relevance to disease. Cytogenet Genome Res. 2008;123:148–155. PubMed

Linzmeier RM, Ganz T. Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. Genomics. 2005;86:423–430. PubMed

Hollox EJ, Barber JC, Brookes AJ, Barber JC. Defensins and the dynamic genome: What we can learn from structural variation at human chromosome band 8p23.1. Genome Res. 2008;18:1686–1697. PubMed

Groth M, Szafranski K, Taudien S, Huse K, Mueller O, et al. High-resolution mapping of the 8p23.1 beta-defensin cluster reveals strictly concordant copy number variation of all genes. Hum Mutat. 2008;29:1247–1254. PubMed

Bentley RW, Pearson J, Gearry RB, Barclay ML, McKinney C, et al. Association of Higher DEFB4 Genomic Copy Number With Crohn's Disease. Am J Gastroenterol. 2009;105:354–359. PubMed

Fellermann K, Stange DE, Schaeffeler E, Schmazl H, Wehkamp J, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006;79:439–448. PubMed PMC

Cukier HN, Pericak-Vance MA, Gilbert JR, Hedges DJ. Sample degradation leads to false-positive copy number variation calls in multiplex real-time polymerase chain reaction assays. Anal Biochem. 2009;386:288–290. PubMed

Field SF, Howson JM, Maier LM, Walker S, Walker NM, et al. Experimental aspects of copy number variant assays at CCL3L1. Nat Med. 2009;15:1115–1117. PubMed PMC

Hollox EJ. Beta-defensins and Crohn's disease: confusion from counting copies. Am J Gastroenterol. 2010;105:360–362. PubMed

Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007;315:848–853. PubMed PMC

Groth M, Wiegand C, Szafranski K, Huse K, Kramer M, et al. Both copy number and sequence variations affect expression of human DEFB4. Genes Immun. 2010:1158–466. PubMed

Armour JA, Palla R, Zeeuwen PL, den Heijer M, Schalkwijk J, et al. Accurate, high-throughput typing of copy number variation using paralogue ratios from dispersed repeats. Nucleic Acids Res. 2007;35:e19. PubMed PMC

Ronaghi M, Karamohamed S, Pettersson B, Uhlén M, Nyrén P. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem. 1996;242:84–89. PubMed

Bakar SA, Hollox EJ, Armour JAL. Allelic recombination between distinct genomic locations generates copy number diversity in human β-defensins. Proceedings of the National Academy of Sciences. 2009;106:853–858. PubMed PMC

Aldous MC, Abu Bakar S, Prescott NJ, Palla R, Soo K, et al. Measurement methods and accuracy in copy number variation: failure to replicate association of low beta-defensin copy number with colonic Crohn's disease. Hum Mol Genet. 2010;19:4930–4938. PubMed PMC

Hollox EJ, Detering JC, Dehnugara T. An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat. 2009;30:477–484. PubMed PMC

Perne A, Zhang X, Lehmann L, Groth M, Stuber F, et al. Comparison of multiplex ligation-dependent probe amplification and real-time PCR accuracy for gene copy number quantification using the beta-defensin locus. Biotechniques. 2009;47:1023–1028. PubMed